Section: Publications

Mary Lee, M.D.

Academic Role: Professor

Faculty Appointment(s) In:
   Cell Biology
   Pediatrics

Representative Publications

Lee MM and Moshang T.  “Endocrine Disorders of the Newborn” In Avery GB, Fletcher MA and MacDonald  MG, eds.  Neonatology:  Pathophysiology and Management of the Newborn, 6^th Edition.  Philadelphia :  Lippincott Williams & Wilkins, 2005, pp pending.

Catlin EA and Lee MM.  “Neonatal endocrinology,” in DeAngelis CD, Feigin RD, McMillan JA, and Warshaw JB, eds.  Oski’s Pediatrics:  Principles and Practice, 4th ed., Philadelphia :  Lippincott, Williams & Wilkins, 2005, pp pending.

Hauser R, Williams P, Altshul L, Korrick S, Peeples L, Patterson D, Turner WE, Lee MM,  Revich B, Zeilert V, and Sergeyev O. Characterization and predictors of serum dioxin levels among adolescent boys in Chapaevsk, Russia.  Organohalogen Compounds, 2004; 66:3245-3251.

Wu XF, Arumugam R, Baker SP, and Lee MM.  Pubertal and adult Leydig cell function in Mullerian Inhibiting Substance (MIS/AMH) deficient mice.  Endocrinology, 2005; 146:589-595 (first published on-line October 28, 2004 ).

Lee MM.  “Molecular Genetic Control of Sex Differentiation,” in Eugster EA and Pescovitz OH, eds.  Pediatric Endocrinology: Mechanisms, Manifestations and Management.  Philadelphia :  Lippincott, Williams and Wilkins, 2004, 231-242.

Hardy O, Worley G, Lee MM, Chaing S, Mackey J, Crissman B, and Kishnani PS.  Hypothyroidism in Down Syndrome: Screening guidelines and testing methodology.  Am J Med Genet, 2004, 124A:436-437.

Misra M, MacLaughlin DT, Donahoe PK and Lee MM.  The role of Mullerian inhibiting substance in the evaluation of phenotypic females with mild degrees of virilization.  J Clin Endocrinol Metab, 2003, 88:787-797.

Lee MM, Sergeyev O, Williams P, Korrick S, Zeilert V, Revich B, and Hauser R. Physical growth and sexual maturation of boys in Chapaevsk, Russia.  J Pediatric Endocrinol, 2003, 16: 169-178.

Lee MM, Misra M, Donahoe PK and MacLaughlin DT.  MIS/AMH in the assessment of cryptorchidism and intersex conditions.   Mol Cell Endocrinol, 2003, 211:91-98.

Salva A, Hardy MP, Wu XF, Sottas CM, MacLaughlin DT, Donahoe PK, and Lee MM.  Mullerian Inhibiting Substance prevents rat Leydig cell degeneration after ethylene dimethanesulphonate (EDS) ablation.  Biol Reprod, 2004, 70:600-607 (first published on-line October 29, 2003 ).

Litton J, Rice A, Friedman N, Oden J, Lee MM and Freemark M.  Insulin pump therapy in infants and preschool children with type 1 diabetes mellitus.  J Ped, 2002, 141:490-495.

Sriraman V, Niu E, Matias JR, Donahoe PK, MacLaughlin DT, Hardy MP and Lee MM.  Mullerian Inhibiting Substance inhibits testosterone synthesis in adult rats.  J Androl, 2001, 22:750-758

Lane AH, Lee MM, Fuller AF, Kehas D, Donahoe PK, MacLaughlin DT.  Diagnostic utility of Mullerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors.  Gynecol Oncol 1999; 73:51-55.

Lee MM, Seah CC, Masiakos P, Sottas C, Preffer F, Donahoe PK, MacLaughlin DTM, and Hardy MP.  Mullerian inhibiting substance type II receptor expression and function in primary rat Leydig cells. Endocrinology, 1999; 140:2819-2827

Lee MM, Donahoe PK,   Silverman B, Hasegawa T, Hasegawa Y, Gustafson ML, Chang YC, and MacLaughlin DT.  Measurements of serum Mullerian Inhibiting Substance in the evaluation of children with nonpalpable gonads.  New Engl J Med, 1997; 336: 1480-1486.  

Phone: 508-856-4280
E-mail: Mary.Lee@umassmemorial.org
Keywords: Reproductive Endocrinology, Transgenic Mice, Cell Biology, Male Reproductive Biology, Testis Development

More on Mary Lee's Research Research | Figures | Publications | Rotations | Biography View All Sections on One Page